Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Assets (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Assets for 12 consecutive years, with $583.5 million as the latest value for Q1 2026.

  • For Q1 2026, Assets rose 102.38% year-over-year to $583.5 million; the TTM value through Mar 2026 reached $583.5 million, up 102.38%, while the annual FY2025 figure was $638.5 million, 81.29% up from the prior year.
  • Assets hit $583.5 million in Q1 2026 for Wave Life Sciences, down from $638.5 million in the prior quarter.
  • Across five years, Assets topped out at $638.5 million in Q4 2025 and bottomed at $146.4 million in Q4 2022.
  • Average Assets over 5 years is $284.7 million, with a median of $241.4 million recorded in 2025.
  • Year-over-year, Assets plummeted 32.67% in 2025 and then soared 102.38% in 2026.
  • Wave Life Sciences' Assets stood at $146.4 million in 2022, then skyrocketed by 87.82% to $274.9 million in 2023, then increased by 28.1% to $352.2 million in 2024, then surged by 81.29% to $638.5 million in 2025, then fell by 8.61% to $583.5 million in 2026.
  • According to Business Quant data, Assets over the past three periods came in at $583.5 million, $638.5 million, and $241.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.